Ryan Beitzell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Centers for Diseases Control and Prevention and the Food and Drug Administration recommended pausing the use of the Johnson & Johnson single-dose COVID-19 vaccine in the U.S. on April 13 due to “a small number of reports of a rare and severe type of blood clot” among those who had received the vaccine, according to the CDC. In nearly 7 million people who received the J&J vaccine, six cases of these blood clots have been reported, all of them among women ages 18 to 48. Previously, the J&J vaccine was one of three COVID-19 vaccine options found at pharmacies and health centers around Athens, along with the two-dose Moderna and Pfizer vaccines. The University of Georgia’s Health Center was offering all three vaccines to students until Tuesday’s CDC guidance was released.

University of georgiaUnited statesAva burgessRyan beitzellRabun nevesGeorgia department of public healthDrug administrationCenters for diseasesUniversity of georgia health centerBaptist churchUniversity health center onDiseases controlHealth centerGeorgia departmentPublic healthMilledge avenue baptist church